Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study
Table 1
Patient baseline characteristics ().
Characteristics
Results
Age (years)
59.2 ± 11.5
Sex (, male/female)
224/190
Body mass index (kg/m2)
25.2 ± 3.6
DM duration (years)
11.0 ± 7.4
Systolic blood pressure (mmHg)
125.4 ± 17.2
Diastolic blood pressure (mmHg)
73.3 ± 10.6
HbA1c (%)
8.6 ± 1.5
LDL-cholesterol (mg/dL)
89.8 ± 39.5
HDL-cholesterol (mg/dL)
46.4 ± 12.0
Triglycerides (mg/dL)
168.0 ± 35.5
eGFR (mL/min/1.73 m2)
68.3 ± 17.6
Antidiabetic drugs (%)
Metformin
74.9
Sulfonylurea
69.8
Thiazolidinedione
3.6
Alpha-glucosidase inhibitor
0.2
RAS inhibitor (%)
56.8
Statin (%)
59.2
Data are presented as means ± standard deviation or frequencies. eGFR: estimated glomerular filtration rate; HbA1c: glycosylated hemoglobin; HDL: high density lipoprotein; LDL: low density lipoprotein; RAS: renin-angiotensin system.
